Currently Viewing
Fibrolamellar Cancer Foundation Helps Lead Liver Cancer Awareness Month
October 12, 2017 – Fibrolamellar Cancer Foundation
DONNA Marathon Weekend
September 28, 2017 – The DONNA Foundation
Brian d'Arcy James Runs the Chicago Marathon to Raise Money for the Cancer Support Community
September 19, 2017 – Cancer Support Community
Putting Ovarian Self-Awareness in Action with Bright Pink
September 06, 2017 – Bright Pink
Five Ways to Reduce Your Risk of Breast and Ovarian Cancer
August 25, 2017 – Bright Pink
How to Assess Your Risk of Breast or Ovarian Cancer
August 24, 2017 – Bright Pink
How to Practice Breast Self-Awareness
August 24, 2017 – Bright Pink
My Husband's Stomach Cancer Changed Our Lives
July 27, 2017 – Leryn Davis
Persisting Gaps in Cancer Care Affect Patient Outcomes
July 18, 2017 – Cancer Support Community

Fibrolamellar Cancer Foundation Helps Lead Liver Cancer Awareness Month

BY Fibrolamellar Cancer Foundation
PUBLISHED October 12, 2017
While October is well known as the "pink" breast cancer awareness month, the Fibrolamellar Cancer Foundation (FCF) reminds the world to think “green” as October is also Liver Cancer Awareness Month.
Fibrolamellar is a very rare form of liver cancer that generally attacks teens and young adults with healthy livers. Sadly, it has a very low survival rate and limited treatment options.

"Unfortunately, there are more types of cancer than there are months of the year," John Hopper, President of the Greenwich-CT based FCF and Co-Chair of the GI Cancers Alliance (GICA) asserted. "Since Fibrolamellar is such a rare and aggressive cancer, Liver Cancer Awareness Month creates an important opportunity to spread the word about the great need for research funding.”

This October, FCF looks to heighten awareness of its green logo, in communicating that Fibrolamellar, and all types of cancers, continually need research funding. "Research for treatments or cures for all cancers are a united goal," Hopper said. "We’re all invested in doing everything we can in the battle against cancer."

FCF is a leading funder of rare liver cancer research. Right now, FCF is working with medical and scientific teams at over a dozen prestigious research institutions, as well as the National Cancer Institute (NCI), to seek new treatments. FCF will host its second research gathering, Fibrolamellar Research Summit - Building a Roadmap Towards a Cure, which will be held in Stamford, Connecticut in early November. This summit will provide an important forum for collaborative exchange amongst some of the world's top rare GI cancer MD’s and PhD’s from academia, industry and government.

About Fibrolamellar Cancer Foundation:

FCF, a public 501c3 nonprofit organization based in Greenwich, CT, was founded in 2009 by 27-year-old Tucker Davis, who lost his life to Fibrolamellar in 2010. FCF has funded nearly $7 million in research at major institutions in the U.S. and internationally. With 100% of all donations going to research, all operating costs for the foundation are funded by the Charles A. and Marna Davis Foundation. For more information or to donate directly, visit and also interact with us on our social media channels: Facebook, Twitter and Instagram.

Donations can also be mailed to:
Fibrolamellar Cancer Foundation, 20 Horseneck Lane, 2nd Floor, Greenwich, CT 06830
Be the first to discuss this article on CURE's forum. >>
Talk about this article with other patients, caregivers, and advocates in the General Discussions CURE discussion group.

Related Articles


Sign In

Not a member? Sign up now!

Sign Up

Are you a member? Please Log In